Logo for Spectrum Pharmaceuticals Inc

Spectrum Pharmaceuticals Investor Relations Material

Latest events

Logo for Spectrum Pharmaceuticals Inc

Q4 2022

Spectrum Pharmaceuticals
Logo for Spectrum Pharmaceuticals

Q1 2023

11 May, 2023
Logo for Spectrum Pharmaceuticals

Q4 2022

22 Mar, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Spectrum Pharmaceuticals Inc

Access all reports
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing and commercializing oncology and hematology drug products. It operates through the following segments: North American Sales, International Sales, and Research and Development. The company's product candidates include FUSILEV , ZEVALIN, VALSTAR, GAMMATOPHOS, KYTRIL, SUTENT, and VORAXAZE. It offers FUSILEV (levoleucovorin) oral granules, ZEVALIN (ibritumomab tiuxetan) for injection for the treatment of patients with indolent non-Hodgkin's lymphoma monitored by x-ray prior to treatment and during treatment cycle number one; cancer of the ovary or fallopian tube. Spectrum Pharmaceuticals, Inc. is based in Henderson, Nevada.